Preferred Label : sucroferric oxyhydroxide;

Details


Main resources

You can consult :


http://www.has-sante.fr/portail/jcms/c_2017120/fr/velphoro
http://www.has-sante.fr/portail/jcms/c_2017120/fr/velphoro-oxyhydroxyde-sucro-ferrique-hypophosphoremiant
2015
false
false
false
France
French
evaluation of the transparency committee
sucroferric oxyhydroxide
administration, oral
hyperphosphatemia
renal insufficiency, chronic
renal dialysis
peritoneal dialysis
treatment outcome
insurance, health, reimbursement
guidelines for drug use
sucroferric oxyhydroxide
sucroferric oxyhydroxide
drug combinations
ferric compounds
sucrose
drug combinations
ferric compounds
sucrose

---
https://www.ema.europa.eu/medicines/human/EPAR/Velphoro
2014
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
sucroferric oxyhydroxide
drug approval
europe
administration, oral
Chewable Tablet Dosage Form
hyperphosphatemia
adult
renal insufficiency
drug therapy, combination
bone diseases
peritoneal dialysis
renal dialysis
chelating agents
chelating agents
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
sucroferric oxyhydroxide
sucroferric oxyhydroxide
drug combinations
ferric compounds
sucrose
drug combinations
ferric compounds
sucrose

---
Nous contacter.
14/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.